SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001214659-24-002623
Filing Date
2024-02-14
Accepted
2024-02-14 12:00:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 lexx130240sc13ga2.htm SC 13G/A 43559
  Complete submission text file 0001214659-24-002623.txt   45306
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Subject) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: SC 13G/A | Act: 34 | File No.: 005-85256 | Film No.: 24634735
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 211 CONGRESS STREET 8TH FLOOR BOSTON MA 02110
Business Address 211 CONGRESS STREET 8TH FLOOR BOSTON MA 02110 617-912-4972
Invenomic Capital Management LP (Filed by) CIK: 0001769456 (see all company filings)

IRS No.: 810795975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A